drugset / Trial / NCT00389883

Anaesthesia for Supratentorial Tumor Resection

NCT00389883

Phase 3 Completed 69 enrolled Assistance Publique - Hôpitaux de Paris
RandomizedParallel-groupDouble-blindTreatment

Summary

This is a double center, multidisciplinary, prospective, randomized, double-blind, with a superiority hypothesis, trial including 100 patients scheduled for resection of a supratentorial brain tumour under general anesthesia.

Timeline

Start
2006-11
Primary completion
2010-01
Completion
2011-11

Drugs

EvaluationDrugModalityDoseRoute
Subject Propofol Small molecule
Subject Remifentanil Small molecule
Subject Sevoflurane Other / unclassified
Subject Sufentanil Other / unclassified

Indications